药物再开发社会影响债券模式及其启示
|
摘要
目的:介绍国外药物再开发社会影响债券为我国提供借鉴和启示。方法:分析国外药物再开发社会影响债券基本内涵和适用条件,并深入探究药物再开发社会影响债券项目运行机制和相关成功案例。结果与结论:药物再开发社会影响债券可以为患者加速获得新疗法,节约医疗卫生费用。结合我国医药产业实际情况,建议借鉴国外药物再开发社会影响债券成功经验,引入社会资本,注重社会效益评价,制定和完善我国药物再开发相关政策。
Objective: To introduce drug Repurposing's social impact bonds abroad in order to provide references and enlightenment for China. Methods: The basic connotation and applicable conditions of drug Repurposing's social impact bonds abroad were analyzed, and the operation mechanism and relevant successful cases of the project on drug repurposing's social impact bonds were explored. Results and Conclusion: The drug Repurposing's social impact bonds can accelerate patients' access to new therapies and save medical care costs. Based on the actual situation of the pharmaceutical industry in China, it is suggested that we learn from the successful experience of the drug Repurposing's social impact bonds abroad, introduce social capital, lay emphasis on social benefit evaluation, formulate and improve the relevant policies of drug repurposing in China.
Objective: To introduce drug Repurposing's social impact bonds abroad in order to provide references and enlightenment for China. Methods: The basic connotation and applicable conditions of drug Repurposing's social impact bonds abroad were analyzed, and the operation mechanism and relevant successful cases of the project on drug repurposing's social impact bonds were explored. Results and Conclusion: The drug Repurposing's social impact bonds can accelerate patients' access to new therapies and save medical care costs. Based on the actual situation of the pharmaceutical industry in China, it is suggested that we learn from the successful experience of the drug Repurposing's social impact bonds abroad, introduce social capital, lay emphasis on social benefit evaluation, formulate and improve the relevant policies of drug repurposing in China.
引文
[1]Sleigh S H,Barton D C L.Repurposing Strategies for Therapeutics[J].Pharmaceutical Medicine,2010,24(3):151-159.
[2]McHugh N,Sinclair S,Roy M,et al.Social Impact Bonds:A Wolf in Sheep's Clothing?[J].Journal of Poverty and Social Justice,2013,21(3):247-257.
[3]Bloom B E.Creating New Economic Incentives for Repurposing Generic Drugs for Unsolved Diseases Using Social Finance[J].Assay&Drug Development Technologies,2015,13(10):606.
[4]Mulgan G,Reeder N,Aylott M,et al.Social Impact Investment:The Challenge and Opportunity of Social Impact Bonds[C]//London School of Economics and Political Science.LSE Library,2012:1-38.
[5]GOV UK.Guidance on Developing a Social Impact Bond[EB/OL].(2017-09-26)[2018-06-20].https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/646733/Knowledge_Box_Guidance_on_developing_a_SIB.pdf.
[6]Cures Within Reach.Mission and Impact[EB/OL].[2018-06-20].http://www.cureswithinreach.org/about-us/cwrmission.
[7]Findacure.Drug Repositioning and Social Impact Bonds[EB/OL].(2015-03-15)[2018-06-20].http://www.findacure.org.uk/drug-repositioning-and-social-impact-bonds/.
[8]Findacure.What is Findacure?[EB/OL].[2018-06-20].http://www.findacure.org.uk/about-us/.
[9]Findacure.The Rare Disease Drug Repurposing Social Impact Bond(RDDR SIB)[EB/OL].(2017-02-28)[2018-06-20].http://www.findacure.org.uk/drugrepurposing/.
[10]Teachey D T,Greiner R,Seif A,et al.Treatment with Sirolimus Results in Complete Responses in Patients with Autoimmune Lymphoproliferative Syndrome[J].British Journal of Haematology,2009,145(1):101-106.
[11]程丹艺.社会影响债券的发展及其对我国新型社会管理模式的启发[J].金融纵横,2013(8):88-92.
[12]国务院办公厅.关于在公共服务领域推广政府和社会资本合作模式指导意见的通知[EB/OL].[2018-06-20].http://www.gov.cn/zhengce/content/2015-05/22/content_9797.htm.
[2]McHugh N,Sinclair S,Roy M,et al.Social Impact Bonds:A Wolf in Sheep's Clothing?[J].Journal of Poverty and Social Justice,2013,21(3):247-257.
[3]Bloom B E.Creating New Economic Incentives for Repurposing Generic Drugs for Unsolved Diseases Using Social Finance[J].Assay&Drug Development Technologies,2015,13(10):606.
[4]Mulgan G,Reeder N,Aylott M,et al.Social Impact Investment:The Challenge and Opportunity of Social Impact Bonds[C]//London School of Economics and Political Science.LSE Library,2012:1-38.
[5]GOV UK.Guidance on Developing a Social Impact Bond[EB/OL].(2017-09-26)[2018-06-20].https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/646733/Knowledge_Box_Guidance_on_developing_a_SIB.pdf.
[6]Cures Within Reach.Mission and Impact[EB/OL].[2018-06-20].http://www.cureswithinreach.org/about-us/cwrmission.
[7]Findacure.Drug Repositioning and Social Impact Bonds[EB/OL].(2015-03-15)[2018-06-20].http://www.findacure.org.uk/drug-repositioning-and-social-impact-bonds/.
[8]Findacure.What is Findacure?[EB/OL].[2018-06-20].http://www.findacure.org.uk/about-us/.
[9]Findacure.The Rare Disease Drug Repurposing Social Impact Bond(RDDR SIB)[EB/OL].(2017-02-28)[2018-06-20].http://www.findacure.org.uk/drugrepurposing/.
[10]Teachey D T,Greiner R,Seif A,et al.Treatment with Sirolimus Results in Complete Responses in Patients with Autoimmune Lymphoproliferative Syndrome[J].British Journal of Haematology,2009,145(1):101-106.
[11]程丹艺.社会影响债券的发展及其对我国新型社会管理模式的启发[J].金融纵横,2013(8):88-92.
[12]国务院办公厅.关于在公共服务领域推广政府和社会资本合作模式指导意见的通知[EB/OL].[2018-06-20].http://www.gov.cn/zhengce/content/2015-05/22/content_9797.htm.